← Back to home
Comparison · Analytics

metatools vs serofoi

A side-by-side editorial comparison of metatools and serofoi — release velocity, themes, recent moves, and the top alternatives to consider.

metatools vs serofoi: at a glance

Featuremetatoolsserofoi
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themespharmaverse, sdtm, adam, clinical-trialsepiverse-trace, serology, force-of-infection, bayesian-inference
Last editorial update1h ago3h ago
WebsiteVisit →Visit →

What is metatools?

SDTM supplemental-qualifier merging got sturdier, then the package went quiet for two years.

metatools provides the utilities that build and check SDTM and ADaM datasets against their metadata in the pharmaverse. The 0.1.6 release in July 2024 is the substantive one: combine_supp() learned to handle zero-row supplemental data, to refuse QNAM columns already present in the source, and to route multiple QNAM values to the same IDVAR, alongside enhanced controlled-terminology checks and record-uniqueness verification. Nothing has shipped since.

Read the full metatools trajectory →

What is serofoi?

serofoi grew a serosurvey simulator alongside the force-of-infection models it was built to fit.

serofoi estimates the force of infection from serological survey data using Bayesian serocatalytic models fitted through Stan. Beyond fitting it now simulates serosurveys — specifying a model and a survey design and generating the data such a survey would produce. The most recent release is visualisation and naming work.

Read the full serofoi trajectory →

metatools vs serofoi: editorial side-by-side

M
metatools
ANALYTICS
0.0

SDTM supplemental-qualifier merging got sturdier, then the package went quiet for two years.

◆ Current state

metatools provides the utilities that build and check SDTM and ADaM datasets against their metadata in the pharmaverse. The 0.1.6 release in July 2024 is the substantive one: combine_supp() learned to handle zero-row supplemental data, to refuse QNAM columns already present in the source, and to route multiple QNAM values to the same IDVAR, alongside enhanced controlled-terminology checks and record-uniqueness verification. Nothing has shipped since.

◆ Where it's heading

The package's development has been concentrated on one function, combine_supp(), which is where the messy realities of supplemental qualifiers surface — whitespace in join keys, empty supp datasets, colliding names. 0.1.6 also drew three first-time contributors, which is the healthiest signal in the history, but no release has followed. Sibling packages have meanwhile been dropping metatools as a dependency.

◆ Prediction

Without a release in two years the package looks stable rather than active; the plausible trigger is a controlled-terminology or dplyr change that forces the checks to be updated.

S
serofoi
ANALYTICS
0.0

serofoi grew a serosurvey simulator alongside the force-of-infection models it was built to fit.

◆ Current state

serofoi estimates the force of infection from serological survey data using Bayesian serocatalytic models fitted through Stan. Beyond fitting it now simulates serosurveys — specifying a model and a survey design and generating the data such a survey would produce. The most recent release is visualisation and naming work.

◆ Where it's heading

The package moved from fitting-only to a fit-and-simulate pair. 0.1.0 added simulation from time- or age-varying force-of-infection trends and simplified the fitted object down to a Stan fit; 1.0.2 broadened simulation into full serosurvey generation with its own vignette. 1.0.3 then spent its effort on naming consistency and plotting options, which is what a package does once its scope is set.

◆ Prediction

With simulation and fitting both in place, the natural next step is tooling that closes the loop between them — recovery checks or study-design guidance built on simulated surveys.

Alternatives to metatools and serofoi

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either metatools or serofoi.

See all metatools alternatives → · See all serofoi alternatives →

Recent activity from metatools and serofoi

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 1y agoserofoiConstant FoI plots, r-hat plotting and shorter parameter names
  2. 1y agoserofoiSerological surveys can now be simulated end to end
  3. 2y agometatoolscombine_supp() hardened; controlled-terminology checks extended
  4. 2y agoserofoiSimulation functions added; fitted output simplified to a Stan fit
  5. 3y agoserofoiFirst release: three force-of-infection models and the core modules
  6. 3y agometatools0.1.4 Update to dplyr and small bug fixes
  7. 4y agometatools0.1.1 first CRAN release

Frequently asked questions

What is the difference between metatools and serofoi?

They serve adjacent needs but don't currently overlap on shipped themes. metatools and serofoi are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is metatools better than serofoi?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. metatools and serofoi are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to metatools?

Top metatools alternatives in Analytics are ranked by recent ship velocity. Browse the "metatools alternatives" section above for the current picks, or visit /alternatives/metatools for the full list with editorial commentary on each.

What are the best alternatives to serofoi?

Top serofoi alternatives in Analytics are ranked by recent ship velocity. Browse the "serofoi alternatives" section above for the current picks, or visit /alternatives/serofoi for the full list with editorial commentary on each.